Legal Representation
Attorney
Brian D. Gildea
USPTO Deadlines
Next Deadline
171 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
April 29, 2026
Extension Available
Until April 29, 2026
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 16, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 16, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 16, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 16, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 29, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 7, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 7, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 7, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 7, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 7, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 22, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 31, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 31, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
biological preparations for the prevention and treatment of cellular abnormalities.; Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"